Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (271-280 of 385) with videos related to

Pageof 39
Sort By:
The Lancet. Oncology|September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trialJohannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
British Journal of Haematology|October 11, 2014
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk diseaseKlaus M Kortüm, Christian Langer, Jorge Monge, et al.
Blood|December 22, 2011
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeFrank G Rücker, Richard F Schlenk, Lars Bullinger, et al.
Cancer Immunology Research|September 19, 2022
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple MyelomaCarlotta Welters, María Fernanda Lammoglia Cobo, Christian Alexander Stein, et al.
Leukemia|July 10, 2018
Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequencesAlberto L'Abbate, Doron Tolomeo, Ingrid Cifola, et al.
Blood|March 25, 2020
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclaxEugen Tausch, Christof Schneider, Sandra Robrecht, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
Leukemia|February 23, 2018
MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequencesAlberto L Abbate, Doron Tolomeo, Ingrid Cifola, et al.
Genome Research|March 12, 2021
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemiaBrian Giacopelli, Min Wang, Ada Cleary, et al.
The New England Journal of Medicine|June 3, 2026
Kidney Transplantation after Clearing Anti-HLA Antibodies with CD19 CAR T CellsJens Schrezenmeier, Hector Rincon-Arevalo, Nils Lachmann, et al.
Pageof 39

Showing results (271-280 of 385) with videos related to

Sort By:
Pageof 39
The Lancet. Oncology|September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trialJohannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
British Journal of Haematology|October 11, 2014
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk diseaseKlaus M Kortüm, Christian Langer, Jorge Monge, et al.
Blood|December 22, 2011
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeFrank G Rücker, Richard F Schlenk, Lars Bullinger, et al.
Cancer Immunology Research|September 19, 2022
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple MyelomaCarlotta Welters, María Fernanda Lammoglia Cobo, Christian Alexander Stein, et al.
Leukemia|July 10, 2018
Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequencesAlberto L'Abbate, Doron Tolomeo, Ingrid Cifola, et al.
Blood|March 25, 2020
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclaxEugen Tausch, Christof Schneider, Sandra Robrecht, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
Leukemia|February 23, 2018
MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequencesAlberto L Abbate, Doron Tolomeo, Ingrid Cifola, et al.
Genome Research|March 12, 2021
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemiaBrian Giacopelli, Min Wang, Ada Cleary, et al.
The New England Journal of Medicine|June 3, 2026
Kidney Transplantation after Clearing Anti-HLA Antibodies with CD19 CAR T CellsJens Schrezenmeier, Hector Rincon-Arevalo, Nils Lachmann, et al.
Pageof 39